New this month:

• Clinical Special Topics 2010
• Reduced duration of common winter infections in the elderly with Actimel
• Micardis approved to reduce cardiovascular risk
• Mirapexin prolonged-release, new once daily tablet for PD

Featured jobs

• Opportunities at the Mater Misericordiae University Hospital
• Registrar Posts in Medical Oncology
• Pfizer Healthcare Ireland are looking to recruit two Medical Advisors

News

Plastic surgeon found guilty of professional misconduct

Staff Reporter | 08 February 2010

An Italian plastic surgeon has been found guilt of professional misconduct by the Medical Council’s Fitness to Practise (FTP) Committee, over his failure in the post-operative care of an Irish patient. The FTP inquiry determined last Friday (February 5) that... Read more

UCD visiting professor is ‘Australian of the Year’

Dara Gantly | 08 February 2010

A youth mental health expert from Victoria, in Ireland last year as a visiting professor at UCD, has been named Australian of the Year 2010. Prof Pat McGorry was presented with the award by Australian Prime Minister Kevin Rudd and... Read more

EU group praises Irish cervical cancer awareness campaign

Brian Herron | 08 February 2010

The Irish Family Planning Association (IFPA) has received international recognition for its campaign to raise awareness of cervical cancer in Ireland. The charitable organisation scooped up the Pearl of Wisdom Award, which is given by the European Cervical Cancer Association... Read more

Clinical Times

Levodopa remains the staple for Parkinson's

Gary Culliton | 05 February 2010

Clinical Update: Parkinson's Disease - In his latest Clinical Update, Gary Culliton reports on the various treatment options available for patients with Parkinson's disease, and examines the latest research targeting diseased neurons and the potential of stem-cell transplantation... Read more

Stem-cell therapy has potential role

Gary Culliton | 05 February 2010

Clinical Update: Parkinson's Disease - There have been important new developments in stem-cell transplantation into Parkinson’s disease patients. A clinical trial, which was followed up recently, showed that the position in the brain into which the stem cells are transplanted... Read more

Research aims to halt disease progression

Gary Culliton | 05 February 2010

Clinical Update: Parkinson's Disease - About 80 per cent of the neurotransmitter dopamine can be depleted from the affected region of the Parkinsonian brain before symptoms begin to develop. Thus, it is imperative that treatments be found to prevent further... Read more